Story Of Pfizer Research PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Story Of Pfizer Research PDF full book. Access full book title Story Of Pfizer Research.

Story of Pfizer Research

Story of Pfizer Research
Author: Philip Handler
Publisher:
Total Pages: 18
Release: 1986
Genre: Story-Pfizer-Research
ISBN:

Download Story of Pfizer Research Book in PDF, ePub and Kindle


25 Years of Innovation

25 Years of Innovation
Author: Ogden Tanner
Publisher:
Total Pages: 214
Release: 1996
Genre: Pharmaceutical industry
ISBN: 9780944641170

Download 25 Years of Innovation Book in PDF, ePub and Kindle


Innovation & Growth - A Case Study of Pfizer

Innovation & Growth - A Case Study of Pfizer
Author: Miriam Mennen
Publisher: GRIN Verlag
Total Pages: 29
Release: 2010-03
Genre: Business & Economics
ISBN: 3640568583

Download Innovation & Growth - A Case Study of Pfizer Book in PDF, ePub and Kindle

Essay from the year 2007 in the subject Business economics - Business Management, Corporate Governance, grade: 69% - B, University of Sunderland (Faculty of Business and Law), course: Innovation & Growth, language: English, abstract: Pfizer Inc. is taken as case study for an innovative company in the pharmaceutical sector. Firstly, the author will look at its mission statement in relation to its key stakeholders. Secondly, the company's overall strategy will be outlined regarding its positioning on the market as well the linkage to key theories which will be discussed and applied. The third part focuses on Pfizer's operational issues. Finally a comparison of the strategic performance and application of theories between Microsoft and Pfizer, both, two highly innovative companies, will be made. Pfizer, as the main case study, was chosen, because it can be defined as a highly innovative company, ranking globally the second by R&D expenditure on the DTI R&D scoreboard (see Appendix 1). However, according to the 'Business Week' the company ranks only on place 55 in the world's most innovative companies, with a margin growth of 1.8% and stock returns of 9.9% between 1995 till 2005. (Business Week, 2006) This provides the evidence that Pfizer is an innovative company.


The Legend of Pfizer

The Legend of Pfizer
Author: Jeffrey L. Rodengen
Publisher: Write Stuff Syndicate
Total Pages: 170
Release: 1999
Genre: Business & Economics
ISBN:

Download The Legend of Pfizer Book in PDF, ePub and Kindle

Founded as a small fine chemicals manufacturer in 1849, Pfizer has established itself as one of the most innovative healthcare companies in the world. Using its famous fermentation process, Pfizer was able to mass produce the wonder drug penicillin during World War II and save thousands of Allied lives. Today, with revenues topping $11 billion, Pfizer's drug pipeline is the envy of competitors, and its animal products are the world standard. The company nears its 150th year in business intent on becoming the world's largest pharmaceutical company. Illustrated with images from the Civil War to present day, The Legend of Pfizer tells the story of a company that has become an integral part of our lives. Individually boxed.


The Body Hunters

The Body Hunters
Author: Sonia Shah
Publisher: New Press, The
Total Pages: 257
Release: 2012-03-13
Genre: Medical
ISBN: 1595588310

Download The Body Hunters Book in PDF, ePub and Kindle

Hailed by John le Carré as “an act of courage on the part of its author” and singled out for praise by the leading medical journals in the United States and the United Kingdom, The Body Hunters uncovers the real-life story behind le Carré's acclaimed novel The Constant Gardener and the feature film based on it. "A trenchant exposé . . . meticulously researched and packed with documentary evidence" (Publishers Weekly), Sonia Shah's riveting journalistic account shines a much-needed spotlight on a disturbing new global trend. Drawing on years of original research and reporting in Africa and Asia, Shah examines how the multinational pharmaceutical industry, in its quest to develop lucrative drugs, has begun exporting its clinical research trials to the developing world, where ethical oversight is minimal and desperate patients abound. As the New England Journal of Medicine notes, “it is critical that those engaged in drug development, clinical research and its oversight, research ethics, and policy know about these stories,” which tell of an impossible choice being faced by many of the world's poorest patients—be experimented upon or die for lack of medicine.


The Vaccine

The Vaccine
Author: Joe Miller
Publisher: St. Martin's Press
Total Pages: 272
Release: 2022-02-01
Genre: Biography & Autobiography
ISBN: 1250280370

Download The Vaccine Book in PDF, ePub and Kindle

Winners of the Paul Ehrlich Prize The dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19. Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world’s first clinically approved inoculation for the coronavirus. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age; it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time. Written by Joe Miller—the Financial Times’ Frankfurt correspondent who covered BioNTech’s COVID-19 project in real time—with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic.


Reviewing Clinical Trials

Reviewing Clinical Trials
Author: Chinese University of Hong Kong
Publisher:
Total Pages: 153
Release: 2010
Genre: Clinical trials
ISBN: 9789881904119

Download Reviewing Clinical Trials Book in PDF, ePub and Kindle

The idea for this manual came from Pfizer in the US, which provided the Clinical Trials Centre at The University of Hong Kong, Hong Kong SAR, PR China with a nonbinding grant for its development. The general project layout protocol was accepted by Pfizer in July 2009. Pfizer has not in any way interfered with the project, except for providing nonbinding comments to the final product. The entire text of this manual was written by Johan PE Karlberg. Marjorie A Speers provided considerable and essential comments on the contents and the first and subsequent drafts. A group of international human research protection experts mostly working in non-profit institutions or organisations - see Contributors for details - reviewed and provided important comments on the contents and final draft. It was solely created with the intention to promote human research protection of participants in clinical trials. This manual will be translated into numerous languages and is provided free of charge as an electronic file over the Internet (http://www.ClinicalTrialMagnifier.com) and offered in print for a fee. The objective beyond this project is to establish educational activities, developed around the manual, and jointly organised with leading academic institutions worldwide.


Drug Truths

Drug Truths
Author: John L. LaMattina
Publisher: John Wiley & Sons
Total Pages: 186
Release: 2012-03-02
Genre: Medical
ISBN: 1118158962

Download Drug Truths Book in PDF, ePub and Kindle

This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. It gives an insider's account of the pharmaceutical industry drug discovery process, the very real costs of misperceptions about the industry, the high stakes--both economic and scientific--of developing drugs, the triumphs that come when new compounds reach the market and save lives, and the despair that follows when new compounds fail. In the book, John LaMattina, former president of Pfizer Global Research and Development, weaves themes critical to a vital drug discovery environment in the context. This is a story that Dr. LaMattina is uniquely qualified to tell.


A Shot to Save the World

A Shot to Save the World
Author: Gregory Zuckerman
Publisher: Penguin
Total Pages: 384
Release: 2021-10-26
Genre: Business & Economics
ISBN: 0593420403

Download A Shot to Save the World Book in PDF, ePub and Kindle

"An inspiring and informative page-turner." –Walter Isaacson Longlisted for the FT/McKinsey Business Book of the Year Award The authoritative account of the race to produce the vaccines that are saving us all, from the #1 New York Times bestselling author of The Man Who Solved the Market Few were ready when a mysterious respiratory illness emerged in Wuhan, China in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug and vaccine makers were slow to react or couldn’t muster an effective response. It was up to a small group of unlikely and untested scientists and executives to save civilization. A French businessman dismissed by many as a fabulist. A Turkish immigrant with little virus experience. A quirky Midwesterner obsessed with insect cells. A Boston scientist employing questionable techniques. A British scientist despised by his peers. Far from the limelight, each had spent years developing innovative vaccine approaches. Their work was met with skepticism and scorn. By 2020, these individuals had little proof of progress. Yet they and their colleagues wanted to be the ones to stop the virus holding the world hostage. They scrambled to turn their life’s work into life-saving vaccines in a matter of months, each gunning to make the big breakthrough—and to beat each other for the glory that a vaccine guaranteed. A #1 New York Times bestselling author and award-winning Wall Street Journal investigative journalist lauded for his “bravura storytelling” (Gary Shteyngart) and “first-rate” reporting (The New York Times), Zuckerman takes us inside the top-secret laboratories, corporate clashes, and high-stakes government negotiations that led to effective shots. Deeply reported and endlessly gripping, this is a dazzling, blow-by-blow chronicle of the most consequential scientific breakthrough of our time. It’s a story of courage, genius, and heroism. It’s also a tale of heated rivalries, unbridled ambitions, crippling insecurities, and unexpected drama. A Shot to Save the World is the story of how science saved the world.


Communities in Action

Communities in Action
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 583
Release: 2017-04-27
Genre: Medical
ISBN: 0309452961

Download Communities in Action Book in PDF, ePub and Kindle

In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also contribute to health inequities, as well as the historic and ongoing interplay of structures, policies, and norms that shape lives. When these factors are not optimal in a community, it does not mean they are intractable: such inequities can be mitigated by social policies that can shape health in powerful ways. Communities in Action: Pathways to Health Equity seeks to delineate the causes of and the solutions to health inequities in the United States. This report focuses on what communities can do to promote health equity, what actions are needed by the many and varied stakeholders that are part of communities or support them, as well as the root causes and structural barriers that need to be overcome.